Morey & Quinn Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$727K Buy
11,587
+160
+1% +$12.8K 0.52% 50
2025
Q4
$1.09M Sell
11,427
-104
-0.9% -$10.2K 0.78% 29
2025
Q3
$1.13M Sell
11,531
-500
-4% -$51.8K 0.83% 28
2025
Q2
$1.29M Sell
12,031
-493
-4% -$49.9K 1.03% 20
2025
Q1
$1.26M Sell
12,524
-163
-1% -$16.4K 1.05% 22
2024
Q4
$1.13M Buy
+12,687
New +$1.12M 0.96% 24

Other funds holding BSX

Morey & Quinn Wealth Partners's BSX Position: Q1 2026 in Review

Morey & Quinn Wealth Partners increased its Boston Scientific (BSX) stake by 1.4% in Q1 2026, buying an estimated $12.8K and bringing the position to 11,587 shares worth $727K. The position accounts for 0.52% of the portfolio, ranked #50.

Morey & Quinn Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.29M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Morey & Quinn Wealth Partners held 11,587 shares of Boston Scientific worth $727K as of Q1 2026.
  • Morey & Quinn Wealth Partners bought 160 Boston Scientific shares in Q1 2026, an estimated $12.8K.
  • Boston Scientific made up 0.52% of Morey & Quinn Wealth Partners's portfolio in Q1 2026, its #50 holding.
  • Morey & Quinn Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Morey & Quinn Wealth Partners's Boston Scientific position peaked at $1.29M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Morey & Quinn Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.